Rutter Matthew D, Saunders Brian P, Wilkinson Kay H, Kamm Michael A, Williams Christopher B, Forbes Alastair
St Mark's Hospital, Harrow, London, United Kingdom.
Gastrointest Endosc. 2004 Sep;60(3):334-9. doi: 10.1016/s0016-5107(04)01710-9.
Patients with long-standing extensive ulcerative colitis are at increased risk for colorectal carcinoma. Because most dysplasia is believed to be macroscopically invisible, recommended surveillance protocols include multiple non-targeted colonic biopsies. It was hypothesized by us that most dysplasia is actually colonoscopically visible. This study assessed the proportion of dysplasia that has been detected macroscopically in patients who underwent colonoscopy surveillance at our center.
A retrospective review was conducted of colonoscopically detected neoplasia (dysplasia or cancer) in patients with ulcerative colitis who underwent surveillance from 1988 through 2002. An established surveillance protocol was used in all cases that included random segmental biopsies every 10 cm throughout the length of the colon, in addition to targeted biopsies of macroscopic lesions. Neoplasia detection was categorized as resulting from either targeted or non-targeted ("random") biopsies. Follow-up information was obtained to the study end.
A total of 525 patients underwent 2204 surveillance colonoscopies. A total of 110 neoplastic areas were detected in 56 patients: 85 (77.3%) were macroscopically visible at colonoscopy, and 25 (22.7%) were macroscopically invisible. Fifty patients (89.3%) had macroscopically detectable neoplasia, and 6 (10.7%) had macroscopically invisible lesions. The frequency of cancer in patients who had endoscopic resection of neoplasia did not differ from that for the surveillance population as a whole (1/40 vs. 18/525; p=1.0, Fisher exact test), irrespective of whether the lesion was thought to be an adenoma or a dysplasia-associated lesion/mass. Conversely, a high proportion of unresectable lesions harbored cancer.
Most dysplastic lesions in ulcerative colitis are visible at colonoscopy. From a clinical perspective, the endoscopic resectability of a lesion is more important than whether it is thought to be a sporadic adenoma or a dysplasia-associated lesion/mass.
长期患有广泛性溃疡性结肠炎的患者患结直肠癌的风险增加。由于大多数发育异常被认为在宏观上不可见,推荐的监测方案包括多次非靶向性结肠活检。我们推测大多数发育异常实际上在结肠镜检查时是可见的。本研究评估了在我们中心接受结肠镜监测的患者中通过肉眼检测到的发育异常的比例。
对1988年至2002年接受监测的溃疡性结肠炎患者结肠镜检查发现的肿瘤(发育异常或癌症)进行回顾性研究。所有病例均采用既定的监测方案,除了对宏观病变进行靶向活检外,还在整个结肠长度上每隔10厘米进行随机分段活检。肿瘤检测分为靶向活检或非靶向(“随机”)活检所致。获取随访信息直至研究结束。
共有525例患者接受了2204次监测结肠镜检查。56例患者共检测到110个肿瘤区域:85个(77.3%)在结肠镜检查时肉眼可见,25个(22.7%)肉眼不可见。50例患者(89.3%)有肉眼可检测到的肿瘤,6例(10.7%)有肉眼不可见的病变。接受肿瘤内镜切除的患者的癌症发生率与整个监测人群的癌症发生率无差异(1/40对18/525;p = 1.0,Fisher精确检验),无论病变被认为是腺瘤还是发育异常相关病变/肿块。相反,高比例的不可切除病变伴有癌症。
溃疡性结肠炎中的大多数发育异常病变在结肠镜检查时可见。从临床角度来看,病变的内镜可切除性比其被认为是散发性腺瘤还是发育异常相关病变/肿块更为重要。